The purpose of this study was to investigate the utility of MRI findings after drug-eluting beads (DEB) - transcatheter arterial chemoembolization (TACE) for @entity157 in predicting @entity1054 ( @entity1054 ). This study included 48 @entity1 with 60 lesions who underwent liver MRI within 3 months after DEB-TACE. MRI was assessed for arterial enhancement pattern, late washout, arterioportal shunt, signal intensity on T2-weighted image, intratumoral septa, enhancing tissue on subtraction images, and treatment response. Cox-regression analysis was performed to identify independent factors to predict @entity1054 . @entity1054 was calculated using the Kaplan-Meier method with the log-rank test. Per lesion, 30 achieved complete remission, 22 had a partial response, and the remaining 8 lesions displayed stable disease on MRI. Arterial enhancement pattern, washout and enhancing tissue on subtraction images from MRI were associated with viable @entity5 on the last follow-up computerized tomography. Arterial enhancement, washout and enhancing tissue on subtraction images were significant predictors of @entity1054 , but only enhancing tissue on subtraction images remained a significant predictor of @entity1054 (P=0.018) in the multivariate analysis. @entity1054 was longer in the group without enhancing tissue on subtraction images compared to the group with enhancing tissue (601 days vs. 287 days, P<0.001). Enhancing tissue on subtraction images from MRI after DEB-TACE is predictive for longer @entity1054 .

MRI Findings and Prediction of Time to Progression of XXXX with @entity157 Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity157 :: ('MESH:D006528', 'Disease') :: ['hepatocellular carcinoma'] @entity1054 :: ('MESH:D000377', 'Disease') :: ['TTP', 'time to progression'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor']
@entity1 :: (9606,Species) :: ['Patients']
